Oncology & Cancer

Increased risk of prostate cancer in men with BRCA2 gene fault

Men with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect the disease earlier, according to researchers funded by Cancer Research ...

Oncology & Cancer

Noninvasive test improves detection of aggressive prostate cancer

A team of researchers from UCLA and the University of Toronto have identified a new biomarker found in urine that can help detect aggressive prostate cancer, potentially saving hundreds of thousands of men each year from ...

Oncology & Cancer

How microchips could help detect prostate cancer

Professor of Electronic Engineering Andrew Flewitt is working with researchers at the Cancer Research UK (CRUK) Cambridge Centre on a more accurate PSA blood test to detect prostate cancer.

Oncology & Cancer

One-off PSA screening for prostate cancer does not save lives

Inviting men with no symptoms to a one-off PSA test for prostate cancer does not save lives according to results from the largest ever prostate cancer trial conducted over 10 years by Cancer Research UK-funded scientists ...

Oncology & Cancer

Prostate cancer screening rates appear to level after recent drop

Declines in prostate specific antigen (PSA) testing that came after changes in government screening guidelines have abated in recent years, according to a new study. Writing in JAMA Internal Medicine, American Cancer Society ...

Oncology & Cancer

PSA test often occurs without discussion of benefits, harms

(HealthDay)—Fewer than one in three men screened with the prostate-specific antigen (PSA) test for prostate cancer talked about the risks and benefits of the test with their doctor, according to a study published online ...

page 1 from 11